389 related articles for article (PubMed ID: 31126830)
1. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
[TBL] [Abstract][Full Text] [Related]
2. Consistency of chronic obstructive pulmonary disease regimens for patients visiting community pharmacies with the Global Initiative for Chronic Obstructive Lung Disease recommendations.
Prosser TR; Bollmeier SG
J Am Pharm Assoc (2003); 2021; 61(3):299-307. PubMed ID: 33549503
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Medication Regimen Complexity of COPD Regimens in Individuals Visiting Community Pharmacies.
Prosser TR; Bollmeier SG
Int J Chron Obstruct Pulmon Dis; 2023; 18():1499-1510. PubMed ID: 37489240
[TBL] [Abstract][Full Text] [Related]
4. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
[TBL] [Abstract][Full Text] [Related]
5. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
Mittal R; Chhabra SK
COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
[TBL] [Abstract][Full Text] [Related]
6. Concordance between reported medication taking behavior and prescription instructions for patients with chronic obstructive pulmonary disease visiting community pharmacies.
Prosser TR; Bollmeier SG
J Am Pharm Assoc (2003); 2022; 62(4):1280-1286. PubMed ID: 35277361
[TBL] [Abstract][Full Text] [Related]
7. COPD management in primary care: an observational, community pharmacy-based study.
Mehuys E; Boussery K; Adriaens E; Van Bortel L; De Bolle L; Van Tongelen I; Remon JP; Brusselle G
Ann Pharmacother; 2010 Feb; 44(2):257-66. PubMed ID: 20103611
[TBL] [Abstract][Full Text] [Related]
8. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
[TBL] [Abstract][Full Text] [Related]
9. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
[TBL] [Abstract][Full Text] [Related]
10. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
11. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
[TBL] [Abstract][Full Text] [Related]
12. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial.
Davis E; Marra C; Gamble JM; Farrell J; Lockyer J; FitzGerald JM; Abu-Ashour W; Gillis C; Hawboldt J
Trials; 2016 Oct; 17(1):502. PubMed ID: 27737686
[TBL] [Abstract][Full Text] [Related]
14. Relationship between symptom burden, medication adherence and spiritual well-being in patients with chronic obstructive pulmonary disease.
Helvaci A; Izgu N; Ozdemir L
J Clin Nurs; 2020 Jul; 29(13-14):2388-2396. PubMed ID: 32221991
[TBL] [Abstract][Full Text] [Related]
15. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896
[TBL] [Abstract][Full Text] [Related]
16. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.
Huang WC; Wu MF; Chen HC; Hsu JY;
NPJ Prim Care Respir Med; 2015 Nov; 25():15063. PubMed ID: 26538368
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Health-Related Quality of Life (HRQOL) in Patients With Chronic Obstructive Pulmonary Disease using the COPD Assessment Test (CAT).
Akor AA; Bamidele A; Erhabor GE
West Afr J Med; 2020; 37(3):275-280. PubMed ID: 32476122
[TBL] [Abstract][Full Text] [Related]
18. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
[TBL] [Abstract][Full Text] [Related]
20. A Pharmacy-Based eHealth Intervention Promoting Correct Use of Medication in Patients With Asthma and COPD: Nonrandomized Pre-Post Study.
Schnoor K; Versluis A; Bakema R; van Luenen S; Kooij MJ; van den Heuvel JM; Teichert M; Honkoop PJ; van Boven JFM; Chavannes NH; Aardoom JJ
J Med Internet Res; 2022 Jun; 24(6):e32396. PubMed ID: 35675120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
